+17 C°
Traffic jam:   0

Johnson & Johnson prepares to deliver the vaccine

23 January 2021
2 min.
Johnson & Johnson prepares to deliver the vaccine

Vaccine trial and delivery

Johnson & Johnson is preparing to present the results of the final trials of its COVID-19 vaccine in the next week or two, according to Anthony Fauci, chief medical officer for infectious diseases in the US.

Shares of Johnson & Johnson rose in early trading on Friday, after the chief infectious disease doctor in the US, Anthony Fauci, said on Thursday that the company will provide data on the final phase of testing of its COVID-19 vaccine in the next week or two.

Shares in J&J have already risen after the company said last week that its vaccine was safe and elicited a meaningful immune response in 90% of volunteers in early-stage trials. The final test of J&J's vaccine was planned to involve 45,000 volunteers.

Approval of J&J's vaccine

On 12 January, J&J chief scientific officer Paul Stoffels said he was awaiting a decision from US regulators in March.

"We are continuing active discussions with regulators, including approval and validation of our manufacturing processes", the company said.

J&J board member Dr Mark McClellan said: "J&J is producing a very large supply, struggling to produce both here in the US and around the world, with the aim of getting enough vaccines for 100 million Americans by spring, around April".

If Johnson & Johnson's vaccine is approved by the FDA for use, it will have big advantages over Pfizer's BioNTech and Moderna vaccines, which are currently approved in the US. The J&J vaccine requires only one dose and does not require storage at low temperatures.

"We have started production of our candidate vaccine and are confident in our ability to meet our delivery commitments for 2021", the company stated.

Covid in the US

Although the US has signed major contracts for vaccine supplies from manufacturers, the country is still behind the original vaccination schedule.

According to the Centers for Disease Control and Prevention, the US has averaged around 883,000 vaccine injections a day over the past six days. Despite this, less than 50% of the 37,960,000 doses distributed have reached people.

Persons3 and Companies6 in the news

Board member of Johnson & Johnson
1 place
Chief scientific officer of Johnson & Johnson
2 place
Chief Medical Advisor to the President
3 place
2 place
3 place
5 place


Rating companies
68 Mention
66 Mention
64 Mention
55 Mention
Dow Jones
51 Mention
50 Mention
35 Mention


News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova

Development Director